Reporting to the Corporate Controller, CARGO Therapeutics is hiring an Accounting Manager for Technical Operations(as well as other R&D,including CMC, Regulatory, Manufacturing, Quality, Tech Dev, Preclinical & Discovery Research). Core responsibilities for the role will include execution of quarterly close activities for Technical Operations and all other Non-Clinical R&D departments. You will actively monitor Tech Ops key milestones, decision points and critical path activities to ensure financial assets, liabilities, and operating expenses are properly reflected, as well as support FP&A to update forecasts and Long-Range Plans, and provide other financial guidance as needed.
The role is based in San Carlos, CA.
WHAT YOU’LL DO AT CARGO THERAPEUTICS
Provide day-to-day Finance leadership and business partnership to the Technical Operations and Research functions including:
Prepare month-end Tech Ops department accruals, including review of CDMO and other reports
Prepare monthly and quarterly reconciliations for accrued manufacturing and related prepaid accounts
Review and analyze contracts, invoices, change orders, and vendor financial reports to compare and reconcile data and determine the impact on Tech Ops accruals
Work with external CDMOs and vendors to ensure that expenses are accurately accounted for
Review purchase requests against budgeted amount and account coding
Prepare flux analysis for assigned accounts
Collaborate with the Tech Ops department and other cross-functional departments to ensure accuracy and completeness of operating expenses
Participate and support the maintenance of Sarbanes-Oxley internal control requirements, and schedules and documentation for SEC reporting
Assist with external audit requests and PBC items for the quarterly and year end audits
Support preparation of financial reporting to senior management and the CARGO Board of Directors
Analyze financial results on a quarterly basis in partnership with functional leadership and Accounting teams to provide actionable insights on CARGO’s ongoing business
Support FP&A’s development of analytics and strategic insights to the CFO and Executive Team to support effective financial decision making
Support potential business development activity through financial analysis and operational support
Embody the collaborative, innovative, and disciplined culture of the CARGO Finance team!
THE RIGHT STUFF: Required Experience & Qualifications
Bachelor’s degree in accounting or equivalent work experience; CPA required
6+ years of experience in accounting positions in a relevant industry setting (biotech, life sciences)
Experience with R&D accruals process; will work closely with our, CMC, and other R&D teams
Self-motivated with the strong work ethic and sense of urgency required for success in a rapidly growing biotech company and an equally critical ability to problem solve in high pressure situations
Process-oriented thinker with experience in process design, implementation, and improvement
Strong written and oral communication skills allowing for presentation of complex financial concepts in a digestible manner to stakeholders with varying degrees of financial experience
Track record of collaboration, stakeholder relationship management, and influencing key decision-makers
Demonstrated intellectual curiosity in the life sciences industry
Highly skilled in use of information technology (such as ERP and financial planning systems)
Well-developed analytical skills that demonstrate the ability to drive from data to analysis to insight
Solid working knowledge of GAAP to facilitate understanding of financial results and forward-looking forecasts
Familiarity with the control and compliance requirements of a public company including knowledge of the Sarbanes-Oxley Act (SOX)
PAY RANGE
The combined pay range for this role is $124,000 - $170,000. Title and salary will be based on our assessment of skills and experience relevant to our needs for the role.
ABOUT CARGO THERAPEUTICS
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. CARGO’s programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved cell therapies, including limited durability of effect, safety concerns and unreliable supply. CARGO is currently evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy. CARGO also plans to evaluate CRG-022 in patients at earlier stages of disease, including LBCL and other hematologic malignancies. Beyond its lead program, CARGO is leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic “cargo” designed to enhance CAR T-cell persistence and trafficking to tumor lesions, as well as to help safeguard against tumor resistance and T-cell exhaustion. CARGO’s founders are pioneers and world-class experts in CAR T-cell therapy, and its team has significant experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. For more information, please visit the CARGO Therapeutics website at https://cargo-tx.com/.
Join us to help make a difference!
EEO & EMPLOYMENT ELIGIBILITY
CARGO Therapeutics, Inc. is committed to building a diverse, equitable, and inclusive company. We provide equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability, or veteran status. CARGO Therapeutics, Inc. also complies with all applicable national, state, and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification required of applicable law.
CARGO Therapeutics requires all new hires to be fully vaccinated against COVID-19 as of their start date. This requirement is a condition of employment at CARGO Therapeutics, and it applies regardless of whether the position is located at a CARGO Therapeutics site or is fully remote. If you are unable to receive the vaccine due to a disability or serious medical condition, or because it is prohibited because of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation.